Suspected adverse events, 2015.

The following article has been produced by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD) to provide a summary of some of the results from its surveillance work carried out in 2015Decrease in number of reports for food-producing speciesIncrease in number of pet animal reportsReports of dogs affected by medicines intended for large animals.

Summary of suspected adverse events, 2014.

The following article has been produced by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD) to provide a summary of some of the results from its surveillance work carried out in 2014.

Suspected adverse events, 2013.

Increase in the number of reports of suspected adverse events in animals, Fewer reports of human adverse events to veterinary medicines, Notable increase in reports relating to products used for treating canine epilepsy. These are some of the results from the surveillance work carried out by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD), as discussed by Giles Davis and colleagues from the VMD.

Suspected adverse events, 2012.

Increase in serious adverse events; Increase in reports involving products marketed under the Small Animal Exemption Scheme; Decrease in injection site reactions. These are some of the results from the surveillance work carried out by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD), as discussed by Giles Davis and colleagues.